These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31037491)

  • 1. Monitoring of visual field over 6 months after active ocular toxoplasmosis.
    Blot J; Aptel F; Chumpitazi BFF; Gain P; Vasseneix C; Savy O; Bouillet L; Pelloux H; Chiquet C
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1481-1488. PubMed ID: 31037491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular Toxoplasmosis in a Tertiary Referral Center in Sydney Australia-Clinical Features, Treatment, and Prognosis.
    Yates WB; Chiong F; Zagora S; Post JJ; Wakefield D; McCluskey P
    Asia Pac J Ophthalmol (Phila); 2019; 8(4):280-284. PubMed ID: 31369405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular toxoplasmosis: clinical features and prognosis of 154 patients.
    Bosch-Driessen LE; Berendschot TT; Ongkosuwito JV; Rothova A
    Ophthalmology; 2002 May; 109(5):869-78. PubMed ID: 11986090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular toxoplasmosis after the fifth decade.
    Labalette P; Delhaes L; Margaron F; Fortier B; Rouland JF
    Am J Ophthalmol; 2002 Apr; 133(4):506-15. PubMed ID: 11931784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual function in human ocular toxoplasmosis.
    Scherrer J; Iliev ME; Halberstadt M; Kodjikian L; Garweg JG
    Br J Ophthalmol; 2007 Feb; 91(2):233-6. PubMed ID: 16987904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular toxoplasmosis: phenotype differences between toxoplasma IgM positive and IgM negative patients in a large cohort.
    Ajamil-Rodanes S; Luis J; Bourkiza R; Girling B; Rees A; Cosgrove C; Pavesio C; Westcott M
    Br J Ophthalmol; 2021 Feb; 105(2):210-215. PubMed ID: 32345603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When biology supports clinical diagnosis: review of techniques to diagnose ocular toxoplasmosis.
    Greigert V; Di Foggia E; Filisetti D; Villard O; Pfaff AW; Sauer A; Candolfi E
    Br J Ophthalmol; 2019 Jul; 103(7):1008-1012. PubMed ID: 31088793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of polymerase chain reaction in blood and aqueous humor in immunocompetent patients with ocular toxoplasmosis.
    Figueroa MS; Bou G; Marti-Belda P; Lopez-Velez R; Guerrero A
    Retina; 2000; 20(6):614-9. PubMed ID: 11131414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual function and macular architecture in patients with inactive zone 2 and 3 toxoplasmic retinochoroiditis.
    Azevedo MH; Moura GL; Camilo EN; Muccioli C; Arantes TE
    Arq Bras Oftalmol; 2015; 78(5):273-7. PubMed ID: 26466223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics, visual acuity outcomes, and factors associated with loss of vision among patients with active ocular toxoplasmosis: A retrospective study in a Thai tertiary center.
    Sittivarakul W; Treerutpun W; Tungsattayathitthan U
    PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012232. PubMed ID: 38843299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Biological Factors Associated With Recurrences of Severe Toxoplasmic Retinochoroiditis Confirmed by Aqueous Humor Analysis.
    Matet A; Paris L; Fardeau C; Terrada C; Champion E; Fekkar A; Cassoux N; Touitou V; LeHoang P; Bodaghi B
    Am J Ophthalmol; 2019 Mar; 199():82-93. PubMed ID: 30502335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal detachment associated with ocular toxoplasmosis.
    Faridi A; Yeh S; Suhler EB; Smith JR; Flaxel CJ
    Retina; 2015 Feb; 35(2):358-63. PubMed ID: 25127047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular manifestations in congenital toxoplasmosis.
    Kodjikian L; Wallon M; Fleury J; Denis P; Binquet C; Peyron F; Garweg JG
    Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):14-21. PubMed ID: 15906073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of ocular toxoplasmosis after LASIK.
    Barbara A; Shehadeh-Masha'our R; Sartani G; Garzozi HJ
    J Refract Surg; 2005; 21(6):759-61. PubMed ID: 16329371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active ocular toxoplasmosis in Turkish patients: a report on 109 cases.
    Tugal-Tutkun I; Corum I; Otük B; Urgancioglu M
    Int Ophthalmol; 2005 Dec; 26(6):221-8. PubMed ID: 17318320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Ocular Toxoplasmosis Presenting to Uveitis Services in a Non-endemic Setting.
    Bhikoo R; Damato EM; Guest S; Sims J
    Korean J Ophthalmol; 2019 Dec; 33(6):514-519. PubMed ID: 31833248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis.
    Moshfeghi DM; Dodds EM; Couto CA; Santos CI; Nicholson DH; Lowder CY; Davis JL
    Ophthalmology; 2004 Apr; 111(4):716-25. PubMed ID: 15051204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Value of Positive Findings of
    Park SW; Kim SH; Kwon HJ; Lee SM; Byon IS; Lee JE
    Ocul Immunol Inflamm; 2019; 27(4):583-590. PubMed ID: 29513626
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of Toxoplasma gondii and Toxocara canis among patients with uveitis.
    Lim SJ; Lee SE; Kim SH; Hong SH; You YS; Kwon OW; Kim HS
    Ocul Immunol Inflamm; 2014 Oct; 22(5):360-6. PubMed ID: 24833105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.